Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Dried Blood Spot Collection Cards Market Size & Growth Forecast 2027–2036, By Segments (End Use, Card Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 12027| Published Date: Sep-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Dried Blood Spot Collection Cards Market size stood at USD 430.5 million in 2026 and is predicted to grow at a 5.61% CAGR from 2027 to 2036, reaching USD 743.06 million by 2036. The industry revenue for 2027 is estimated at USD 450.82 million.

Base Year Value (2026)
USD 430.5 million
CAGR (2027-2036)
5.61%
Forecast Year Value (2036)
USD 743.06 million
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Dried Blood Spot Collection Cards Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 37.13% market share in 2026, driven by established laboratory workflows, widespread newborn screening programs, and standardized specimen collection practices across clinical and research settings.
  • Asia Pacific is expected to grow at a 5.47% CAGR due to expanding adoption of accessible diagnostic sampling, decentralized testing, and cost-effective collection methods across developing healthcare systems.

Segment Momentum

  • Whatman 903 held the largest 2026 market share at 43% due to its established use in routine testing programs, consistent sample collection performance, and compatibility with standard laboratory workflows.
  • Diagnostics centers are expanding fastest because their high-throughput testing, standardized workflows, and efficient sample processing align well with dried blood spot collection methods, supporting greater operational scalability.

Market Expansion Drivers

  • Expanding newborn screening programs increasing adoption of dried blood spot diagnostic collection methods.
  • Rising infectious disease testing initiatives supporting wider use of low-volume blood sampling technologies.
  • Growing forensic and remote diagnostic applications strengthening demand for portable sample preservation solutions.

Leading Market Participants

  • Key players in the dried blood spot collection cards market include F. Hoffmann-La Roche Ltd (Switzerland), QIAGEN N.V. (Germany), PerkinElmer Inc. (United States), Shimadzu Corporation (Japan), Ahlstrom-Munksjö Oyj (Finland), Pall Corporation (United States), Cytiva (United States), Eastern Business Forms, Inc. (United States), Archimed Life Science GmbH (Germany).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 430.5 million
  • 2027 Estimated Market Size: USD 450.82 million.
  • Projected Market Size: USD 743.06 million by 2036
  • Growth Forecast: 5.61% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Hospitals & Clinics (End Use) | Whatman 903 (Card Type) | New Born Screening (NBS) (Application)
  • Emerging Opportunity Segment: Diagnostics Centers (End Use) | FTA (Card Type) | Forensics (Application)
Market Dynamics

Market Growth Drivers and Industry Trends

Expanding newborn screening programs increasing adoption of dried blood spot diagnostic collection methods

Expansion of newborn screening initiatives is supporting the dried blood spot collection cards market because these programs require practical methods for obtaining and preserving small blood samples from infants. Dried blood spot collection enables blood to be obtained through minimally invasive sampling and transported for laboratory analysis without the logistical requirements associated with conventional liquid blood specimens. The approach is particularly useful for screening programs that need standardized sample collection across hospitals, clinics, and community healthcare settings. As public health systems broaden screening coverage for inherited, metabolic, and other conditions, the convenience of dried sample handling is increasing its relevance within newborn diagnostic workflows.

Rising infectious disease testing initiatives supporting wider use of low-volume blood sampling technologies

Infectious disease testing initiatives are contributing to the dried blood spot collection cards market as healthcare programs increasingly require accessible methods for collecting and transporting blood samples from diverse populations. Dried blood spot techniques require only a small sample volume and can simplify specimen handling in locations where conventional blood collection and refrigerated transportation may be difficult. This makes the approach useful for screening and surveillance activities conducted in community settings, remote locations, and resource-constrained environments. The ability to stabilize collected specimens for subsequent laboratory testing can also support broader testing workflows where immediate processing of liquid blood samples is not practical.

Growing forensic and remote diagnostic applications strengthening demand for portable sample preservation solutions

Growing use of dried blood sampling in forensic investigations and remote diagnostic applications is expanding the dried blood spot collection cards market by increasing demand for convenient sample preservation and transportation methods. In forensic settings, compact blood collection formats can facilitate specimen handling and storage when biological evidence must be transported for laboratory examination. Remote diagnostic programs can similarly benefit from collection methods that allow samples to be obtained outside conventional laboratory environments and transferred for later analysis. Their portability, low sample-volume requirements, and simplified storage characteristics make dried blood spot cards suitable for decentralized testing workflows and field-based sample collection.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Expanding newborn screening programs increasing adoption of dried blood spot diagnostic collection methods 2.00% High North America, Europe High Near Term
Rising infectious disease testing initiatives supporting wider use of low-volume blood sampling technologies 1.80% High Asia Pacific, Africa High Mid Term
Growing forensic and remote diagnostic applications strengthening demand for portable sample preservation solutions 1.40% Moderate Latin America, Asia Pacific Emerging Long Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Dried Blood Spot Collection Cards Market
Largest Region
North America
37.13% Market Share in 2026

North America (Largest Region)

North America accounted for the largest share of 37.13% in 2026 in the dried blood spot collection cards market, supported by established healthcare and laboratory infrastructure, broad adoption of minimally invasive sample collection methods, and strong demand for convenient biological specimen handling. The region's mature diagnostic ecosystem facilitates the use of dried blood spot sampling across clinical testing, screening, and research applications. Growing emphasis on efficient sample collection, storage, and transportation further reinforces market adoption.

Asia Pacific (Fastest-Growing Region)

Asia Pacific represents the fastest-growing region, supported by expanding diagnostic capabilities, rising healthcare access, and increasing demand for efficient sample collection methods. The growing penetration of laboratory and screening services is encouraging adoption of dried blood spot technologies, particularly where simplified collection and specimen handling can improve testing accessibility. Investments in healthcare infrastructure and the broader shift toward decentralized and convenient diagnostic approaches are also contributing to the region's growth trajectory.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Laboratory Quality Focus

Germany places strong emphasis on high-quality dried blood spot collection cards that support reliable laboratory diagnostics and validated testing protocols. The market benefits from demand for standardized sampling solutions aligned with clinical research and public health laboratory requirements.

France 🇫🇷

Public Health Diagnostics

France continues to utilize dried blood spot collection cards across national screening initiatives and clinical laboratory networks. The market prioritizes dependable sample preservation and standardized collection practices that enhance diagnostic consistency for preventive healthcare programs.

Italy 🇮🇹

Specialized Laboratory Adoption

Italy is expanding the application of dried blood spot collection cards within specialized diagnostic laboratories and regional healthcare systems. Healthcare providers are focusing on practical collection solutions that simplify logistics while maintaining analytical performance across diverse testing requirements.

Japan 🇯🇵

Precision Diagnostic Support

Japan is strengthening the use of dried blood spot collection cards in precision diagnostics and long-term disease monitoring programs. Healthcare institutions are seeking collection products that improve sample integrity while supporting efficient laboratory processing across specialized testing applications.

South Korea 🇰🇷

Digital Healthcare Integration

South Korea is incorporating dried blood spot collection cards into expanding digital healthcare and molecular diagnostic services. The country is encouraging convenient sample collection methods that complement remote healthcare delivery and advanced laboratory testing capabilities.

United States 🇺🇸

Clinical Screening Expansion

The U.S. continues to emphasize dried blood spot collection cards for newborn screening, decentralized clinical research, and infectious disease monitoring. Healthcare providers are prioritizing standardized sample collection workflows that integrate efficiently with laboratory automation and expanding diagnostic programs.

Segment Analysis

Segment Leadership and Growth Trends

Dried Blood Spot Collection Cards Market Share (%), by End Use, 2026

Hospitals & Clinics
Diagnostics centers
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report

End Use Segment Analysis: Hospitals & Clinics (Largest Segment) vs Diagnostics Centers (Fastest-Growing Segment)

The dried blood spot collection cards market was anchored by hospitals & clinics, which held a 70.4% share in 2026. These healthcare facilities rely on convenient sample collection methods to support diagnostic testing while simplifying the handling and transportation of biological specimens. Dried blood spot cards offer practical advantages for sample collection, storage, and transport, making them useful where conventional specimen handling can be more resource-intensive. Their compatibility with decentralized and laboratory-based diagnostic workflows supports continued demand across hospitals and clinics.

Diagnostics centers are experiencing stronger adoption as the need for accessible and efficient sample collection supports broader use of dried blood spot techniques. These cards can facilitate specimen handling and transportation while reducing logistical complexity associated with conventional sample collection methods. Growing emphasis on decentralized diagnostics, streamlined laboratory workflows, and convenient specimen management is supporting increasing utilization within diagnostic centers.

Card Type Segment Analysis: Whatman 903 (Largest Segment) vs FTA (Fastest-Growing Segment)

Whatman 903 accounted for a 43% share of the dried blood spot collection cards market in 2026, maintaining its leading position through established use in biological specimen collection and analytical workflows. Its suitability for collecting and preserving blood samples supports applications where reliable specimen handling is essential. Familiarity with established card formats and their integration into existing laboratory procedures further contributes to sustained demand for whatman 903 cards.

FTA cards are gaining traction as laboratories and research-oriented users seek collection platforms that simplify sample preservation, handling, and downstream analysis. Their ability to support convenient biological sample management makes them valuable in workflows where transportation and storage efficiency are important. Increasing use of dried blood spot methodologies across diagnostic and research applications is creating favorable conditions for broader adoption of FTA cards.

Segment Sub-Segment Largest Segment Fastest Growing
End Use Hospitals & Clinics, Diagnostics Centers, Others Hospitals & Clinics Diagnostics Centers
Card Type Whatman 903, Ahlstrom 226, FTA, Others Whatman 903 FTA
Application New Born Screening (NBS), Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, CRO/Research, Others New Born Screening (NBS) Forensics
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Top players in the dried blood spot collection cards market:

1. F. Hoffmann-La Roche Ltd (Switzerland)

2. QIAGEN N.V. (Germany)

3. PerkinElmer Inc. (United States)

4. Shimadzu Corporation (Japan)

5. Ahlstrom-Munksjö Oyj (Finland)

6. Pall Corporation (United States)

7. Cytiva (United States)

8. Eastern Business Forms Inc. (United States)

9. Archimed Life Science GmbH (Germany)

The dried blood spot collection cards market is being shaped by the increasing need for convenient sample collection, remote diagnostics, and efficient disease screening programs. Manufacturers are focusing on improved sample preservation technologies, contamination control, and regulatory-compliant materials to enhance testing reliability. Advancements in decentralized healthcare and laboratory automation are also supporting innovation within the dried blood spot collection cards market.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
F. Hoffmann-La Roche Ltd (Switzerland)
QIAGEN N.V. (Germany)
PerkinElmer Inc. (United States)
Shimadzu Corporation (Japan)
Ahlstrom-Munksjö Oyj (Finland)
Pall Corporation (United States)
Cytiva (United States)
Eastern Business Forms Inc. (United States)
Archimed Life Science GmbH (Germany).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Capitainer Jan-24 Capitainer launched miQro Lab Solutions, a U.S.-based laboratory in Rhode Island, to accelerate integration of its self-sampling and micro-sampling technologies into the U.S. healthcare system. The initiative is positioned to support broader adoption of decentralized blood collection solutions and improve clinical accessibility and operational efficiency.
Neoteryx (Trajan Scientific) Sep-22 Neoteryx, part of Trajan Scientific, launched a program supporting micro-sampling pilot studies by providing Mitra devices to healthcare and research organizations. The initiative enables evaluation of remote blood sampling feasibility across clinical and research environments, supporting adoption of decentralized sample collection methods.
Capitainer Sep-22 Capitainer reported positive performance results for its qDBS volumetric dried blood spot card, demonstrating accurate diagnostic outcomes for phenylketonuria. The technology addresses limitations of conventional DBS cards by improving volume consistency and reducing variability caused by hematocrit effects, strengthening reliability in remote blood sampling applications.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Dried Blood Spot Collection Cards Market — Custom Segments

Segment Sub-Segment
Testing Workflow Manual Testing Workflows, Automated Testing Workflows, High-Throughput Testing Workflows
Analyte Type Nucleic Acids, Proteins & Biomarkers, Small Molecules & Metabolites, Therapeutic Drugs
Procurement Channel Direct Manufacturer Procurement, Distributors & Medical Supply Wholesalers, Institutional & Government Procurement

Dried Blood Spot Collection Cards Market — Custom TOC

Custom Chapter Custom Details
Newborn Screening Program Expansion Assessment
  • Screening Program Coverage Expansion
  • Testing Volume and Program Requirements
  • Collection Infrastructure Needs
  • Public Health Implementation Priorities
  • Emerging Screening Opportunities
Decentralized Diagnostics Adoption Assessment
  • Shift Toward Distributed Testing
  • Point-of-Care and Near-Patient Applications
  • Sample Collection in Remote Settings
  • Workflow and Logistics Advantages
  • Adoption Barriers and Enablers
Home-Based Sample Collection Opportunity Assessment
  • Consumer and Patient Home-Collection Use Cases
  • Remote Testing Workflows
  • Sample Stability and Transport Requirements
  • Provider and Laboratory Integration
  • Commercialization Opportunities

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the current size of the dried blood spot collection cards market?

As of 2027 the market size of dried blood spot collection cards is valued at USD 450.82 million.

What is the forecasted size of the dried blood spot collection cards industry?

Dried Blood Spot Collection Cards Market size stood at USD 430.5 million in 2026 and is predicted to grow at a 5.61% CAGR from 2027 to 2036, reaching USD 743.06 million by 2036.

Which healthcare delivery trends are accelerating demand for dried blood spot collection cards?

Expanding newborn screening and infectious disease testing programs are increasing demand for collection cards that support standardized sampling, simplified transport, and efficient laboratory workflows across large-scale public health initiatives.

How are remote and decentralized testing applications influencing purchasing decisions in the market?

Organizations increasingly favor portable collection solutions that preserve sample integrity during transport and delayed analysis, supporting forensic investigations and remote diagnostic workflows where mobility, storage stability, and operational efficiency are essential.

Which card type leads the dried blood spot collection cards market?

Whatman 903 held the largest 2026 market share at 43% due to its established use in routine testing programs, consistent sample collection performance, and compatibility with standard laboratory workflows.

Why are diagnostics centers the fastest-growing end-use segment in the dried blood spot collection cards market?

Diagnostics centers are expanding fastest because their high-throughput testing, standardized workflows, and efficient sample processing align well with dried blood spot collection methods, supporting greater operational scalability.

What factors support North America's leadership in the dried blood spot collection cards market?

North America held a 37.13% market share in 2026, driven by established laboratory workflows, widespread newborn screening programs, and standardized specimen collection practices across clinical and research settings.

Why is Asia Pacific the fastest-growing region for dried blood spot collection cards?

Asia Pacific is expected to grow at a 5.47% CAGR due to expanding adoption of accessible diagnostic sampling, decentralized testing, and cost-effective collection methods across developing healthcare systems.

Who are the leading players in the dried blood spot collection cards landscape?

Key players in the dried blood spot collection cards market include F. Hoffmann-La Roche Ltd (Switzerland), QIAGEN N.V. (Germany), PerkinElmer Inc. (United States), Shimadzu Corporation (Japan), Ahlstrom-Munksjö Oyj (Finland), Pall Corporation (United States), Cytiva (United States), Eastern Business Forms, Inc. (United States), Archimed Life Science GmbH (Germany).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →